jRCTs051210034RecruitingNot Applicable
Clinical Trial for the Evaluation of Efficacy and Safety of Contrast Enhanced Ultrasonography-guided Sentinel Lymph Node Biopsy after Introducing Twirl Breast Marker for Axillary Lymph Node-positive Breast Cancer
Not provided0 sites20 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 20
- Primary Endpoint
- -
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Single Arm Study
- Intervention Model
- Single Assignment
- Primary Purpose
- Treatment Purpose
- Masking
- Open(masking Not Used)
Eligibility Criteria
- Ages
- 20age old over to 90age old not (—)
- Sex
- Female
Inclusion Criteria
- •(1) Patients with the ability to consent who are 20 years old or older and younger than 90 years old at the time of obtaining informed consent
- •(2) Clinically T1-2N1M0 breast cancer patients with 1 to 2 positive axillary lymph nodes of whicn at least one axillary lymph node has been confirmed to harbor metastasis by fine needle aspiration cytology
- •(3) Patients whose condition are expected to be stable for longer than 6 months at the time of obtaining the informed consent
- •(4) Patients for whom a written consent has been obtained for participation in this study
Exclusion Criteria
- •(1) Patients with palpable hard nodes
- •(2) Patients with radiologically proven matted nodes or gross extranodal disease
- •(3) Patients who have been treated with preoperative chemotherapy or hormonal therapy for breast cancer
- •(4) Patients who are during or possibilities of pregnancy
- •(5) Patients who are allergic to metal or egg
- •(6) Patients with coronary artery disease
- •(7) Patients who seem not eligible for the present study
Outcomes
Primary Outcomes
-
Ratio of patients who have spared axillary lymph node dissection
Secondary Outcomes
No secondary outcomes reported
Investigators
Similar Trials
Completed
Not Applicable
Contrast-enhanced Ultrasound (CEUS) for determining muscular Perfusion after oral intake of L-Citrulline, L-Arginine, and galloylated epicatechines.Examination of different sport supplement ingredients for their potency of vasodilation in skeletal muscle.DRKS00016972niversität Heidelberg, Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie30
Recruiting
Not Applicable
The use of ultrasound in the therapy of patients with blocked arteries of the lower limb.peripheral arterial occlusions, peripheral vascular disease, vascular disease, lower limb occlusive disease, acuut perifeer vaatlijden, acute vaatocclusieNL-OMON27379VU University Medical Center20
Completed
Phase 2
The application of contrast-enhanced ultrasound to facilitate thrombolysis in patients with acute peripheral arterial occlusions.NL-OMON46851Vrije Universiteit Medisch Centrum20
Active, not recruiting
Phase 1
ltrasound with contrast as additional treatment for blocked arteries in the lower limb.EUCTR2014-003469-10-NLVU University Medical Center20
Active, not recruiting
Phase 1
Prospective ultrasound based study of lymphatic vessels using ultrasound contrast agentMedDRA version: 20.0Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10054561Term: Post-mastectomy lymphedema syndromeSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10036389Term: Postmastectomy lymphedema syndromeSystem Organ Class: 100000004863EUCTR2018-004389-33-FIOlli Lahtinen160